2023
DOI: 10.1039/d3an01473h
|View full text |Cite
|
Sign up to set email alerts
|

In situ grown magnetic COF@MOF with a phosphoserine anchor for in-depth N-glycopeptide analysis in serum

Yimin Guo,
Shuwen Hua,
Baichun Wang
et al.

Abstract: A hydrophilic phosphoserine-functionalized magnetic organic framework composite (termed Fe3O4@COF@MOF-PS) was synthesized by in situ growth strategy for effective capture of N-glycopeptides. Fe3O4@COF@MOF-PS exhibited high sensitivity (0.2 fmol μL-1), outstanding exclusion...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…Glycoproteins play crucial roles in many fundamental physiological and disease processes, such as intercellular interactions, immune responses, and tumor development. , The glycosylated proteins occupy over 50% of human proteins, and the abnormal glycosylation patterns of proteins are closely related to the origin and progress of a number of diseases, like cancer, autoimmune disorders, cardiovascular diseases, and neurodegenerative diseases. So many glycoproteins have been regarded as biomarkers in clinical diagnosis. The current methods to detect glycoproteins mainly rely on mass spectroscopy and enzyme-linked immunosorbent assays, which are either expensive or time-consuming. Moreover, skilled personnel and centralized instruments are typically needed to perform these measurements.…”
Section: Introductionmentioning
confidence: 99%
“…Glycoproteins play crucial roles in many fundamental physiological and disease processes, such as intercellular interactions, immune responses, and tumor development. , The glycosylated proteins occupy over 50% of human proteins, and the abnormal glycosylation patterns of proteins are closely related to the origin and progress of a number of diseases, like cancer, autoimmune disorders, cardiovascular diseases, and neurodegenerative diseases. So many glycoproteins have been regarded as biomarkers in clinical diagnosis. The current methods to detect glycoproteins mainly rely on mass spectroscopy and enzyme-linked immunosorbent assays, which are either expensive or time-consuming. Moreover, skilled personnel and centralized instruments are typically needed to perform these measurements.…”
Section: Introductionmentioning
confidence: 99%